Radiation Oncology
Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.
Getty Images
News | Lung Imaging | April 22, 2020
April 22, 2020 — Value in Health, the official journal of ISPOR — the professional society for health economics and...
News | Interventional Radiology | April 21, 2020
April 21, 2020 — Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture...
PTW Beamscan MR for Elekta Unity
News | Radiation Oncology | April 17, 2020
April 17, 2020 — PTW has installed the first Beamscan MR motorized 3-D water phantom in North America at the Princess...
Sponsored Content
Power injectors can improve efficiency and patient safety, for example, ensuring that contrast agent is not wasted due to the lack of a saline bolus. Image courtesy of Lior Molvin
Blog | Contrast Media | July 31, 2019
Patient safety and operational efficiency are behind the development of modern contrast media, selection and...
News | Coronavirus (COVID-19) | April 17, 2020
April 17, 2020 — OneOncology, the national partnership of independent community oncologists, said today that enrolling...
News | Radiation Therapy | April 16, 2020
April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (...
News | PET Imaging | April 09, 2020
April 9, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (...
Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)
News | Radiation Therapy | April 07, 2020
April 7, 2020 — An international panel of cancer experts has recommended a one-week course of radiotherapy and delaying...
News | Proton Therapy | April 06, 2020
April 6, 2020 — Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced...
Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.
Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new...
News | Radiation Oncology | April 01, 2020
April 1, 2020 — ViewRay, Inc. announced a strategic collaboration with VieCure, an artificial intelligence (AI)...
News | Prostate Cancer | March 30, 2020
March 30, 2020 — In the wake of the COVID-19 pandemic, a team of radiation oncologists from the U.S. and U.K. is...
Women are more likely to be cured of cancer by radiotherapy but the side effects are worse. Image by Mark Kostich
News | Radiation Therapy | March 30, 2020
March 30, 2020 — Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side...
Iva Speck, MD, explains research showing that novel, fully digital, high-resolution positron emission tomography/computed tomography imaging of small brain stem nuclei can provide clinicians with valuable information concerning the auditory pathway in patients with hearing impairment. The research is featured in The Journal of Nuclear Medicine (read more at http://jnm.snmjournals.org/content/current). Video courtesy of Iva Speck, University Hospital Freiburg, Germany.
News | PET-CT | March 26, 2020
March 26, 2020 — Novel, fully digital, high-resolution positron emission tomography/computed tomography (PET/CT)...
News | Prostate Cancer | March 23, 2020
March 23, 2020 — Results from a randomised controlled trial involving 300 prostate cancer patients find that a...
Age‐standardized, delay‐adjusted overall cancer incidence rates for 2012 through 2016 are illustrated among males and females by racial/ethnic group. Racial/ethnic groups are mutually exclusive. Data for the non‐Hispanic American Indian/Alaska Native (AI/AN) population are restricted to Indian Health Service Purchased/Referred Care Delivery Area (PRCDA) counties. API indicates Asian/Pacific Islander. Chart courtesy of ACS Journals
News | Radiation Oncology | March 16, 2020
March 16, 2020 — The Annual Report to the Nation on the Status of Cancer finds that cancer death rates continued to...
News | Stereotactic Body Radiation Therapy (SBRT) | March 13, 2020
March 13, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (...
News | Radiation Dose Management | March 13, 2020
March 13, 2020 — The British Institute of Radiology (BIR) and a working party of U.K. radiological professional bodies...
M. Minhaj Siddiqui, M.D., associate professor of surgery at the University of Maryland School of Medicine, discusses benefits of MRI-targeted biopsy to more precisely diagnose aggressive prostate cancers. (c) University of Maryland Greenebaum Comprehensive Cancer Center
News | Prostate Cancer | March 05, 2020
March 5, 2020 — Using a combination of magnetic resonance imaging (MRI) to target and sample suspicious prostate tissue...
News | Stereotactic Body Radiation Therapy (SBRT) | February 27, 2020
February 27, 2020 — Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its...
An example of the MRI scans showing long-term and short-term survival indications. Image courtesy of Case Western Reserve University
News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — Glioblastoma is an aggressive, killer disease. While victims of this fast-moving brain tumor...
